Surgery versus targeted radiation for lung spots from colorectal cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial compares two treatments for lung spots that have spread from colorectal cancer: surgery to remove them versus a precise type of radiation (called stereotactic ablative radiotherapy). It aims to find out which approach offers better control and quality of life for patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have 1 to 3 lung spots that started from colorectal cancer, and both surgery and radiation are possible options for you.
- Your primary colorectal cancer was treated with the goal of curing it.
- If you had liver spots before, they were successfully treated with the goal of curing them.
- You are able and willing to fill out quality-of-life questionnaires.
- You have no cancer spread outside the liver or lungs, and no other cancer within the last 5 years (except certain low-risk ones).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how targeted radiation (SBRT) affects cancer biology and immune cells in people with colon cancer that has spread only to a small number of lung nodules. Your tumor tissue will be analyzed to see what changes after treatment.
This study tests a precise radiation technique called SABR to treat cancer that has spread to a few spots. It aims to see if this approach can help control the cancer better than usual treatment, especially for lung, prostate, colorectal, or other solid tumors with limited spread.
This trial studies giving targeted high-dose radiation (SBRT) to liver metastases from colorectal cancer after initial treatment, with the goal of improving long-term control or cure. It may help people who have a limited number of liver spots that doctors think can be treated safely and effectively.
This trial tests whether treating all liver tumors with surgery, ablation, or radiation is better than continuing standard chemotherapy for people with colorectal cancer that has spread only to the liver. It's for those whose liver tumors have been controlled by initial chemotherapy and are considered removable.
This trial tests whether focused radiation (SBRT) can treat 1 to 3 metastases in people with colorectal cancer that has spread but is still low or intermediate risk. It may be an option if you are starting first or second line systemic therapy and your primary tumor is under control.
This trial compares two types of highly focused radiation (ablative radiosurgery versus stereotactic radiation in 5 sessions) for people with a small number of metastases in the bone. It aims to find which approach controls these spots with fewer side effects while keeping the treatment “radical,” meaning trying to wipe out the targeted lesions.
Hear when a new Lung Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.